These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12974100)
1. [Development of tumor vaccine on gynecologic cancer]. Xu BL; Li Y; Cui H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):487-91. PubMed ID: 12974100 [TBL] [Abstract][Full Text] [Related]
2. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation. Seo SH; Jin HT; Park SH; Youn JI; Sung YC Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccines for the treatment of cervical cancer. Sin JI Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217 [TBL] [Abstract][Full Text] [Related]
4. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545 [TBL] [Abstract][Full Text] [Related]
5. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer. Wu TC Eur J Immunol; 2007 Feb; 37(2):310-4. PubMed ID: 17273998 [TBL] [Abstract][Full Text] [Related]
12. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity]. Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282 [TBL] [Abstract][Full Text] [Related]
13. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [TBL] [Abstract][Full Text] [Related]
14. Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Williamson AL; Passmore JA; Rybicki EP Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392 [TBL] [Abstract][Full Text] [Related]
15. [Prophylactic and therapeutic vaccination against human papillomavirus]. Brun JL; Riethmuller D J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860 [TBL] [Abstract][Full Text] [Related]
16. [Gynecologic cancer--prevention strategy of cervical neoplasms with vaccine]. Ochiai K Gan To Kagaku Ryoho; 2010 Feb; 37(2):221. PubMed ID: 20235385 [No Abstract] [Full Text] [Related]
17. Vaccination strategies for the prevention of cervical cancer. Maclean J; Rybicki EP; Williamson AL Expert Rev Anticancer Ther; 2005 Feb; 5(1):97-107. PubMed ID: 15757442 [TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles. Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Hooijberg E Gynecol Oncol; 2005 Mar; 96(3):897-901. PubMed ID: 15721448 [TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer. Le Buanec H; Cohen L; Paturance S; Burny A; Gallo RC; Zagury D Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):667-71. PubMed ID: 12899461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]